Status:
UNKNOWN
Detection of Tumor DNA in Blood Samples From Cancer Patients
Lead Sponsor:
Lexent Bio, Inc.
Conditions:
Cancer
Tumors
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to employ genomic detection methodologies to measure the relative amount of tumor nucleic acids in the blood of a cancer patient with diagnosed metastatic disease that is eith...
Eligibility Criteria
Inclusion
- Age 18 years or older
- Have metastatic disease with from a solid tumor (e.g. breast, lung, colon, pancreas, ovary, prostate...) or stage II or III solid tumors undergoing curative surgery or neoadjuvant therapy followed by surgery
- Starting treatment or a new line of treatment
- Able to understand and grant informed consent
- Able to have their blood drawn
Exclusion
- Unable to grant informed consent or comply with all study procedures.
- Has a hematological malignancy, i.e. myeloma, lymphoma, MDS, leukemia
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT02288754
Start Date
December 1 2014
End Date
November 1 2020
Last Update
August 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Care Associates
Torrance, California, United States, 90277